#USA #ClorDiSys #TIR 17 #Chlorine Dioxide #Branchburg

Introduction

The Association for the Advancement of Medical Instrumentation (AAMI) has made significant strides by incorporating chlorine dioxide gas into their latest Technical Information Report (TIR) 17, titled "Compatibility of Materials Subject to Sterilization." This decision highlights the increasing need for effective and safe sterilization methods in the medical industry. The report emphasizes the compatibility of materials treated with chlorine dioxide gas, a contribution notably backed by ClorDiSys Solutions Inc.

The Role of ClorDiSys

Based in Branchburg, New Jersey, ClorDiSys Solutions has been a frontrunner in developing chlorine dioxide gas sterilization methods. The company drew on extensive testing and peer-reviewed studies to provide scientific backing for the material compatibility ratings in TIR 17. Their efforts hinge on the growing need for alternatives to traditional sterilization processes that pose environmental and health risks, including ethylene oxide and gamma irradiation.

Why Chlorine Dioxide Gas?

Chlorine dioxide possesses several advantages over other sterilization techniques. It is recognized for being non-carcinogenic, non-explosive, and free from harmful residuals—characteristics that make it more appealing amidst a backdrop of increasing scrutiny over the environmental impacts of existing methods. Furthermore, its gaseous state allows it to penetrate complex areas effectively, ensuring an even distribution that’s challenging for vaporized sterilants to achieve.

The inclusivity of chlorine dioxide in TIR 17 is pivotal, especially as it demonstrates the ability to sterilize a broader range of materials. This expands upon its utility, especially in disinfecting cellulosic products which often face challenges with other low-temperature methods.

Implications for Medical Technology

One of the major hurdles with conventional sterilization techniques is their limitations concerning advanced medical technology, specifically devices embedded with batteries. Chlorine dioxide's non-explosive properties at use concentrations allow it to effectively sterilize these advanced medical technologies, a significant advancement that opens new corridors for device manufacturing and application.

The Technical Foundation

The generation method for chlorine dioxide gas utilized by ClorDiSys was initially developed by Johnson and Johnson. This technique produces a non-acidic gas noted for its material gentleness, making it an ideal choice for comprehensive sterilization processes. The gas's characteristics and the overall efficiency of the process have further fortified its position in TIR 17, providing an easy and efficient sterilization cycle that is considerably shorter than that of ethylene oxide.

In-house sterilization capabilities are also a prominent feature of ClorDiSys. Facilities can execute sterilization cycles at about one-tenth the time required by ethylene oxide, significantly trimming down supply chain times.

Conclusion

Since its inception in 2001, ClorDiSys has established itself as a leader in the field of sterilization solutions, driven by innovative technologies and the commitment to protecting medical instruments. The inclusion of chlorine dioxide gas in AAMI’s TIR 17 marks a crucial step in fostering safer and more efficient sterilization methods in healthcare, opening doors for future advancements in medical device sterilization. The impact of this development cannot be understated, as it reflects broader trends towards sustainability and effectiveness in medical sterilization practices.

For more information about these advancements or to learn about ClorDiSys's sterilization solutions, reach out to their media contact:

Emily Lorcheim
Phone: 908-236-4100
Email: [email protected]
Address: 50 Tannery Rd, Suite 1, Branchburg, NJ 08876